Medtronic plc (FRA:2M6)
Germany · Delayed Price · Currency is EUR 82.27
-0.53 (-0.64%)
At close: Feb 20, 2026
Medtronic Cash Flow Statement
Financials in millions USD. Fiscal year is May - April.
Millions USD. Fiscal year is May - Apr.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jan '26 Jan 23, 2026 | Apr '25 Apr 25, 2025 | Apr '24 Apr 26, 2024 | Apr '23 Apr 28, 2023 | Apr '22 Apr 29, 2022 | Apr '21 Apr 30, 2021 |
Net Income | 4,613 | 4,662 | 3,676 | 3,758 | 5,039 | 3,606 |
Depreciation & Amortization | 2,931 | 2,710 | 2,647 | 2,697 | 2,707 | 2,702 |
Asset Writedown & Restructuring Costs | 151 | 151 | 371 | 61 | 457 | - |
Stock-Based Compensation | 451 | 429 | 393 | 355 | 359 | 344 |
Provision & Write-off of Bad Debts | 129 | 123 | 90 | 73 | 58 | 128 |
Other Operating Activities | 427 | 23 | 94 | 62 | -385 | 161 |
Change in Accounts Receivable | -162 | -433 | -391 | -576 | -477 | -761 |
Change in Inventory | -617 | -292 | -139 | -939 | -560 | 78 |
Change in Accounts Payable | 289 | 209 | 391 | 696 | 213 | 531 |
Change in Other Net Operating Assets | -927 | -538 | -345 | -148 | -65 | -549 |
Operating Cash Flow | 7,285 | 7,044 | 6,787 | 6,039 | 7,346 | 6,240 |
Operating Cash Flow Growth | -0.11% | 3.79% | 12.39% | -17.79% | 17.72% | -13.74% |
Capital Expenditures | -1,875 | -1,859 | -1,587 | -1,459 | -1,368 | -1,355 |
Cash Acquisitions | - | -98 | -211 | -1,867 | -91 | -994 |
Investment in Securities | -483 | 269 | -307 | -171 | -190 | -463 |
Other Investing Activities | -149 | -249 | -261 | 4 | -10 | -54 |
Investing Cash Flow | -2,507 | -1,937 | -2,366 | -3,493 | -1,659 | -2,866 |
Short-Term Debt Issued | - | - | 1,073 | 2,284 | - | 2,789 |
Long-Term Debt Issued | - | 3,209 | - | 5,409 | - | 7,172 |
Total Debt Issued | 1,920 | 3,209 | 1,073 | 7,693 | - | 9,961 |
Short-Term Debt Repaid | - | -1,070 | - | -2,279 | - | -3,164 |
Long-Term Debt Repaid | - | - | - | -6,012 | -1 | -7,367 |
Total Debt Repaid | -2,930 | -1,070 | - | -8,291 | -1 | -10,531 |
Net Debt Issued (Repaid) | -1,010 | 2,139 | 1,073 | -598 | -1 | -570 |
Issuance of Common Stock | 527 | 508 | 284 | 308 | 429 | 474 |
Repurchase of Common Stock | -874 | -3,235 | -2,138 | -645 | -2,544 | -652 |
Common Dividends Paid | -3,628 | -3,589 | -3,666 | -3,616 | -3,383 | -3,120 |
Other Financing Activities | -221 | -184 | -3 | -409 | 163 | -268 |
Financing Cash Flow | -5,206 | -4,361 | -4,450 | -4,960 | -5,336 | -4,136 |
Foreign Exchange Rate Adjustments | 335 | 188 | -230 | 243 | -231 | 215 |
Miscellaneous Cash Flow Adjustments | - | - | - | - | 1 | - |
Net Cash Flow | -93 | 934 | -259 | -2,171 | 121 | -547 |
Free Cash Flow | 5,410 | 5,185 | 5,200 | 4,580 | 5,978 | 4,885 |
Free Cash Flow Growth | -1.04% | -0.29% | 13.54% | -23.39% | 22.38% | -18.87% |
Free Cash Flow Margin | 15.25% | 15.46% | 16.07% | 14.67% | 18.87% | 16.22% |
Free Cash Flow Per Share | 4.20 | 4.02 | 3.91 | 3.44 | 4.42 | 3.61 |
Cash Interest Paid | 768 | 762 | 826 | 606 | 540 | 582 |
Cash Income Tax Paid | 1,902 | 1,819 | 1,622 | 1,548 | 996 | 1,250 |
Levered Free Cash Flow | - | 4,206 | 5,447 | 10,059 | -1,164 | 4,787 |
Unlevered Free Cash Flow | - | 4,662 | 5,896 | 10,424 | -818.63 | 5,365 |
Change in Working Capital | -1,417 | -1,054 | -484 | -967 | -889 | -701 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.